Medical Research and Clinical Trials

Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Targets Cancer’s Protectors, Not Just the Cancer Itself

• Medical Research and Clinical Trials

Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Targets Cancer’s Protectors, Not Just the Cancer Itself

Suro Senen July 5, 2026

NEW YORK, NY – January 22, 2024 – In a significant paradigm shift for cancer treatment, scientists...

Read More Read more about Mount Sinai Scientists Unveil "Trojan Horse" Immunotherapy That Targets Cancer’s Protectors, Not Just the Cancer Itself

Unlocking the Colorectal Cancer Paradox: MSK Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

• Medical Research and Clinical Trials

Unlocking the Colorectal Cancer Paradox: MSK Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

Iffa Jayyana July 5, 2026

New York, NY – For decades, the role of regulatory T (Treg) cells in cancer has presented...

Read More Read more about Unlocking the Colorectal Cancer Paradox: MSK Study Reveals Dual Nature of Immune Cells, Paving Way for Precision Immunotherapy

Breakthrough IgE Antibody Reverses Immune Suppression in Ovarian Cancer, Offering New Hope

• Medical Research and Clinical Trials

Breakthrough IgE Antibody Reverses Immune Suppression in Ovarian Cancer, Offering New Hope

Siti Muinah July 5, 2026

London, UK – In a landmark development that could redefine the treatment landscape for ovarian cancer, researchers...

Read More Read more about Breakthrough IgE Antibody Reverses Immune Suppression in Ovarian Cancer, Offering New Hope

Thermo Fisher Scientific Partners with Arcturus Therapeutics to Accelerate Cystic Fibrosis Therapy Development and Commercialization

• Medical Research and Clinical Trials

Thermo Fisher Scientific Partners with Arcturus Therapeutics to Accelerate Cystic Fibrosis Therapy Development and Commercialization

Nana Muazin July 5, 2026

A groundbreaking strategic collaboration between Thermo Fisher Scientific and Arcturus Therapeutics is set to significantly advance the...

Read More Read more about Thermo Fisher Scientific Partners with Arcturus Therapeutics to Accelerate Cystic Fibrosis Therapy Development and Commercialization

Re-evaluating Hormone Therapy: New Research Uncovers Surprising Cardiovascular Benefits for Menopausal Women

• Medical Research and Clinical Trials

Re-evaluating Hormone Therapy: New Research Uncovers Surprising Cardiovascular Benefits for Menopausal Women

Iffa Jayyana July 4, 2026

Hershey, PA – For decades, the decision to embark on hormone therapy (HT) during the menopause transition...

Read More Read more about Re-evaluating Hormone Therapy: New Research Uncovers Surprising Cardiovascular Benefits for Menopausal Women

Celea Therapeutics Secures $180 Million to Advance Promising IPF Treatment into Pivotal Phase III Trial

• Medical Research and Clinical Trials

Celea Therapeutics Secures $180 Million to Advance Promising IPF Treatment into Pivotal Phase III Trial

Nila Kartika Wati July 4, 2026

A significant financial infusion is set to propel deupirfenidone, an investigational therapy for idiopathic pulmonary fibrosis (IPF),...

Read More Read more about Celea Therapeutics Secures $180 Million to Advance Promising IPF Treatment into Pivotal Phase III Trial

Groundbreaking Research Reveals Age-Related Blood Mutations Fuel Aggressive Cancers, Worsening Patient Outcomes

• Medical Research and Clinical Trials

Groundbreaking Research Reveals Age-Related Blood Mutations Fuel Aggressive Cancers, Worsening Patient Outcomes

Siti Muinah July 4, 2026

London, UK – In a significant stride for cancer research, an international collaborative team of scientists from...

Read More Read more about Groundbreaking Research Reveals Age-Related Blood Mutations Fuel Aggressive Cancers, Worsening Patient Outcomes

A Paradigm Shift in Cancer Immunology: Erythropoietin’s Unexpected Role in Unleashing Anti-Cancer Immunity

• Medical Research and Clinical Trials

A Paradigm Shift in Cancer Immunology: Erythropoietin’s Unexpected Role in Unleashing Anti-Cancer Immunity

Azzam Bilal Chamdy July 4, 2026

STANFORD, CA – April 24, 2024 – In a discovery that redefines our understanding of cancer immunology,...

Read More Read more about A Paradigm Shift in Cancer Immunology: Erythropoietin’s Unexpected Role in Unleashing Anti-Cancer Immunity

A New Horizon in Breast Cancer Prevention: Combination Therapy Shows Promise for At-Risk Women

• Medical Research and Clinical Trials

A New Horizon in Breast Cancer Prevention: Combination Therapy Shows Promise for At-Risk Women

Pevita Pearce July 4, 2026

ANN ARBOR, MI – A significant proportion of women in the United States, particularly those navigating the...

Read More Read more about A New Horizon in Breast Cancer Prevention: Combination Therapy Shows Promise for At-Risk Women

Revolution Medicines’ Zoldonrasib Shows Promising Dual Potential in Pancreatic Cancer Treatment

• Medical Research and Clinical Trials

Revolution Medicines’ Zoldonrasib Shows Promising Dual Potential in Pancreatic Cancer Treatment

Laily UPN July 4, 2026

San Francisco, CA – Revolution Medicines, a clinical-stage oncology company, has unveiled compelling interim clinical data for...

Read More Read more about Revolution Medicines’ Zoldonrasib Shows Promising Dual Potential in Pancreatic Cancer Treatment